Related Experiment Video
Updated: Jun 18, 2026
10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
[From the viewpoint of pediatrics].
1Fukuoka National Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 11, 2009
Summary
Childhood allergic diseases are rising, with over 80% of patients showing atopic tendencies. Effective management requires considering environmental factors, parental involvement, and developmental stages for better outcomes.
Area of Science:
- Pediatrics
- Allergology
- Environmental Health
Context:
- Allergic diseases are increasingly prevalent in children, with over 80% exhibiting atopic tendencies.
- Environmental factors significantly influence the development, management, and prognosis of childhood allergies.
- Unique challenges in pediatric allergy care include patient communication, growth, and environmental exposures.
Purpose:
- To highlight key considerations for managing allergic diseases in children.
- To emphasize the critical role of environmental control in pediatric allergy management.
- To address specific challenges in treating childhood allergic conditions, including exercise-induced asthma and adolescent adherence.
Summary:
- Effective treatment of childhood allergic diseases necessitates a holistic approach, acknowledging parental involvement, the child's growth, and background influences.
- Environmental control is paramount for disease management and prevention in pediatric patients.
- Specific considerations include managing exercise-induced asthma, the impact of early respiratory infections, and adolescent-specific challenges like compliance and lifestyle factors.
Impact:
- Provides a framework for healthcare providers to optimize the care of children with allergic diseases.
- Underscores the importance of a multidisciplinary approach involving parents and addressing environmental triggers.
- Aims to improve long-term outcomes and quality of life for children affected by allergic conditions.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...